A B S T R A C T In studies with the human promyelocytic leukemia cell line HL-60, we defined changes in intermediary purine metabolism that appear to contribute to the regulation of terminal maturation in myeloid cells. When HL-60 cells were exposed to compounds that induce maturation, consistent alterations in purine metabolism were found to occur within 24 h of culture.
A B S T R A C T In studies with the human promyelocytic
leukemia cell line HL-60, we defined changes in intermediary purine metabolism that appear to contribute to the regulation of terminal maturation in myeloid cells. When HL-60 cells were exposed to compounds that induce maturation, consistent alterations in purine metabolism were found to occur within 24 h of culture.
Perturbation of guanosine nucleotide synthesis and decreases of up to 50% in intracellular guanylate pool sizes were associated with the induced maturation of these cells in response to diverse inducing agents. While immature HL-60 cells were observed to synthesize purine nucleotides by both de novo and salvage pathways, the activity of both pathways decreased in cells induced to mature, although the relative contribution of purine salvage increased. Moreover, incorporation of the salvage pathway precursor, [14C] hypoxanthine from the intermediate, inosine monophosphate (IMP), into guanylates was reduced by -65% in induced HL-60 cells, reflecting decreased activity of both hypoxanthine phosphoribosyltransferase and IMP dehydrogenase. When various inhibitors of IMP dehydrogenase (mycophenolic acid, 3-deazaguanosine, and 2-f3-D-ribofuranosylthiazole-4-carboxamide) were evaluated for their effects upon HL-60 cells, each agent was found to induce the cells to mature morphologically and functionally. Like other inducers, these agents decreased HL-60 cell proliferation and caused the cells to acquire an ability to phagocytose opsonized yeast and reduce nitroblue tetrazolium. Each agent reduced intracellular INTRODUCTION Terminal differentiation of eukaryotic cells reflects both a selection of genetic information encoded in DNA and expression of this information in the production of cellspecific proteins and other constituents. Although gene selection appears to be controlled principally by structural and metabolic determinants that are confined to the cell's nucleus and to the chromosomes and nuclear proteins, gene expression may be controlled to a critical degree by the metabolic environment within the cell as a whole. In this study, we have used the human leukemic cell line, HL-60, to examine the role of purine nucleotides (NTD)' and their biosynthesis in controlling the terminal differentiation of myeloid cells.
The HL-60 cell line, derived originally from the peripheral blood of a patient with promyelocytic leukemia, can be maintained in continuous culture to provide a renewable source of homogenously immature myeloid cells (2) . Maturation of these cells is arrested at the early promyelocyte stage. However, it is possible to induce the cells to undergo further differentiation in vitro, and it is this attribute that makes HL-60 cells useful for studying metabolic events that accompany and may contribute to the regulation of myeloid cell maturation (3) .
When exposed to various compounds in culture (e.g., dimethyl sulfoxide, dimethyl formamide [DMF] , retinoic acid [RA] ), HL-60 cells acquire certain morphologic and functional characteristics of mature neutrophils, including an ability to phagocytose and kill microorganisms (2) (3) (4) and to respond to chemotactic stimuli (5) . These inducible functions characteristic of mature phagocytes are associated with the expression of complement and chemotactic factor receptors and with the development of an activatable oxidase system that can generate H202 and mediate nitroblue tetrazolium (NBT) reduction (3) (4) (5) (6) .
Purine NTD metabolism is an appropriate focus for studies of metabolic events that regulate the terminal maturation of myeloid clls. Triphosphorylated purine NTD provide the energy for DNA replication and for RNA transcription and translation (reviewed in references 7 and 8), and they are substrates for protein kinases that regulate these events (reviewed in reference 9). Moreover, there is diverse experimental evidence to suggest a role for purine NTD metabolism in the control of cellular maturation. Studies with the Friend erythroleukemia cell line, for example, have shown that cellular maturation can be promoted by purine bases or purine analogues (hypoxanthine [Hx] , 6 -thioguanine, and 6-mercaptopurine) which inhibit NTD biosynthesis (10, 11) . It has also been observed that lymphoblastic, mono-and myeloblastic leukemia cells express abnormal activity levels of enzymes that regulate the intermediary metabolism of purine NTD, such as adenosine deaminase (12) (13) (14) (15) , inosine monophosphate dehydrogenase (IMPD) (16) , and 5'-methyl thioadenosine phosphorylase (17) .
We examined purine NTD metabolism in HL-60 cells both in maintenance culture and under conditions in which the cells were induced to mature. Changes in NTD pool sizes and NTD biosynthesis as well as morphologic and functional changes associated with cellular maturation were evaluated throughout in vitro culture periods. In these studies, we observed that purine salvage is favored as the predominant pathway of NTD biosynthesis in HL-60 cells undergoing maturation. We also observed that certain perturbations in guanylate metabolism are consistent features of induced maturation. Decreases in guanosine NTD pools consistently accompanied maturation; moreover, these changes in NTD pools, which occurred early during induced maturation, could be attributed in part to a discrete inhibition of guanosine NTD biosynthesis. We also determined that inhibitors of IMPD (IMP: NADoxidoreductase, EC 1.2.1.14), an enzyme that mediates guanosine NTD biosynthesis from IMP, are active inducers of maturation. Thus, these studies support the concept that the rate of guanosine NTD biosynthesis and the size of guanosine NTD pools have a role in regulating terminal maturation in myeloid cells. Our studies of HL-60 cells also focused attention upon IMPD, an enzyme of intermediary purine metabolism, for the activity of this enzyme appears to be a determinant of the induced maturation of these cells. Purine NTD were chromatographed on an anion-exchange microparticulate column (Partisil-10 SAX, Whatman, Inc., Clifton, NJ). The mobile phase consisted of buffers A (0.01 M potassium phosphate, pH 3.4) and B (0.8 M potassium phosphate, pH 4.3). Buffer A was pumped isocratically for 11 min, after which a linear gradient was established by the addition of buffer B (0-80% B to A over 30 min) at a flow rate of 1.6 ml/min. Purine nucleosides and bases were separated by a reverse-phase method using an Ultrasphere-5 ODS (Altex Scientific Inc.) high-density packed microparticulate column. The mobile phase, consisting of eluant A (0.01 M potassium phosphate, pH 5.6) was pumped isocratically for 3 min, followed by the addition of eluant B (methanol/water, 70:30) in a linear gradient to a final concentration of 40% B to A. Quantification of all compounds was by an external standard method (22) . clear to cytoplasmic ratio, loss of nucleoli, condensation of nuclear chromatin, increased nuclear eccentricity and pleomorphism, and increased cytoplasmic neutrophilia. Morphologic maturation along neutrophilic lines was most evident with RA and DMF, whereas cells exposed to Hx developed a morphology more characteristic of monocytes.
METHODS
With induced maturation of HL-60 cells, cellular proliferation slowed. As is illustrated in Fig. 1 , an inhibition of cell growth was evident after 48 h of culture with each inducing agent and was most pronounced with Hx.
Changes in purine NTD pools during induced maturation of HL-60 cells. Adenosine and guanosine NTD, recoverable from uninduced and induced HL-60 cells during 6 d culture, were quantified by HPLC analysis of perchlorate extracts. As shown in Fig. 2 (Fig. 2) . However, in cells induced to mature, there was in all cases a significant decrease in guanosine NTD pools, which was apparent by 24 h of induced maturation and which persisted throughout the 6-d culture periods (Fig. 2 ). An increased adenylate-to-guanylate ratio (AXP/GXP) was also found to be a consistent characteristic of induced (Table III) , and this finding indicated that reductions in GDP and GTP pools which characterized HL-60 cell induction could be explained at least in part by an inhibition of guanylate biosynthesis from the intermediate IMP (Fig. 3 ). uninduced HL-60 cells could be estimated from radiotracer studies using ["4C]Hx by calculating the incorporation of radiolabel into XMP and guanylates (29) . In a similar manner, the apparent activity of the salvage pathway enzyme, hypoxanthine phosphoribosyltransferase (HPRT), which catalyzes the conversion of Hx to IMP could be estimated by summing radiolabel incorporation into adenylates, IMP, XMP, and guanylates (29) . Estimates of the relative apparent activities of these enzymes indicated that both were decreased in HL-60 cells induced to mature by RA or by DMF. As shown in Table V , the sum of all derivatives of Hx was decreased by -70% in induced cells when compared with uninduced cells indicating inhibition of HPRT J Sp act = radioactivity (dpm X 10-2)/nmol. (step 2, Fig. 3 ). There was also an additional decrease in the levels of guanylate derivatives of IMP, indicating inhibition of IMPD as well (step 1, Fig. 3 ). In contrast, there was no decrease in the production of adenylate derivatives of IMP that could not be accounted for by the inhibition of IMP production (data not shown).
In related studies, induced and uninduced HL-60 cells were incubated with [8-14C] guanosine (Table VI) . These studies showed that guanosine could be used directly by the cells to form guanylates, bypassing bio-
HYPOXANTHINE ( Salvage ) FIGURE 3 De novo and salvage pathways for synthesis of purine NTD. Steps of the biosynthetic pathways, (1) IMPD, (2) HPRT, and (3) enzymes of the de novo pathway, e.g., phosphoribosylpyrophosphate amidotransferase and ribose-5-phosphate aminotransferase, are indicated. Inhibition of these steps would be expected to result in decreased NTD production in general and decreased guanosine NTD production in particular. (27) , or 2-fl-D-ribofuranosylthiazole-4-carboxamide (28) at varying doses for 3-6-d culture periods. Each of these agents inhibited cellular proliferation and induced maturation of the cells. As shown in Table VII and Fig. 5 , reduced GXP and the induction of cellular maturation occurred in an equivalent, doserelated fashion. These agents, as expected, also significantly decreased the biosynthesis of guanylates via salvage of Hx (Fig. 6) .
Impaired cellular proliferation alone, however, was found not to be associated with the induction of HL- There was a consistently observed decrease in guanosine NTD pools with cellular maturation. This decrease in guanylates occurred early, before the cells had expressed their differentiated phenotype. On the other hand, no consistent alterations in adenosine NTD pools were found to occur with induced maturation. Primarily because of decreases in guanosine NTD pools, AXP/GXP were greater in induced cells than in immature, uninduced cells, as were the AXP/GXP measured in normal blood neutrophils.
Analysis of NTD biosynthesis in HL-60 cells showed that decreased guanylate pools in induced cells could be accounted for at least in part by an inhibition of NTD production. Both the utilization of radiolabeled glycine to form NTD by the de novo pathway and the utilization of radiolabeled Hx to form NTD by the salvage pathway (Fig. 3) were markedly reduced once HL-60 cells were induced to mature. However, the relative inhibition of the de novo pathway was greater than that of the salvage pathway. Moreover, the inhibition of guanosine NTD biosynthesis from IMP was greater than that of adenosine NTD biosynthesis.
These studies showed that impaired NTD biosynthesis in cells undergoing induced maturation was associated with decreased production of IMP whether by de novo synthesis or by salvage. These studies also indicated that an additional step in the biosynthesis of guanosine NTD was inhibited, i.e., the production of XMP from IMP. Thus, the results suggest that enzymatic steps in the de novo pathway and in the salvage of Hx to form IMP (HPRT) were down-regulated in induced cellular maturation. It should be noted, however, that decreased utilization of glycine for purine synthesis by the de novo pathway in induced cells could also indicate an increased competition for this amino acid by protein synthetic activity. Nonetheless, it was also evident that induced maturation was associated with an inhibition of IMPD, which mediates the first step in the biosynthesis of guanylates from IMP.
A number of compounds that have attracted interest as antineoplastic agents have been shown recently to be specific inhibitors of IMPD. Three such agents, mycophenolic acid, 3-deazaguanosine, and 2-f3-D-ribofuranosylthiazole-4-carboxamide, were evaluated for their effects upon HL-60 cells. Each compound was found to inhibit guanylate biosynthesis via IMP, and to cause a decrease in guanylate pools and an increased AXP/ GXP in the cells. Each compound also inhibited cellular proliferation and induced cellular maturation. Considered together, then, these studies indicate that guanosine NTD pool sizes, the production of guanosine NTD, and the activity of IMPD, which mediates guanylate biosynthesis from IMP, can influence the regulation of terminal maturation in myeloid cells.
Decreased intracellular concentrations of guanosine NTD in induced HL-60 cells may be caused in part by an increase in the utilization of guanylates during cellular maturation. It is possible, for example, that there is increased consumption of guanosine NTD for RNA production or to provide energy by hydrolysis of GTP for the burst of protein synthesis that has been observed in induced HL-60 cells (5) . However, the finding of decreased NTD biosynthetic activity in cells undergoing maturation and the observation that inhibitors of guanylate production induce maturation clearly suggest that a depletion of guanosine NTD is not simply a consequence of cellular maturation, but rather that it triggers maturation or permits maturation to occur.
The association of reduced GXP and cellular maturation defined by our studies has not been described previously in eukaryotic cells. However, this association has been observed with prokaryotes. In certain species of bacteria, decreases in GTP concentrations have been found not only to accompany but also to induce sporulation (30, 31) .
Intracellular concentrations of guanosine NTD could affect cellular maturation by influencing the activity of a variety of regulatory proteins or enzymes. GTP is known, for example, to be a cofactor for adenylate cyclase (32) and for ribosomal proteins that mediate transcription of messenger RNA and the assembly of polypeptides (7) (8) (9) . In this regard, it is of interest that the product of the c-src oncogene of rat-derived murine sarcoma viruses has been characterized as a GTP-binding protein (33) . Three cellular oncogenes have been identified in HL-60 cells: c-myc, c-abl, and c-ras (34, 35) . The manner in which onc gene products may interfere with the normal terminal differentiation of cells is unknown, but their characteristic of GTP binding suggests that this NTD may be required for their activity.
We find it of particular interest that altered guanylate production in induced HL-60 cells appears to involve a down-regulation of IMPD and that inhibitors of this enzyme promote maturation, for alterations in intracellular levels of this enzyme have been associated with malignant transformation. Drugs that inhibit IMPD have also been shown to exhibit significant antitumor effects (reviewed in reference 36). Rat hepatoma cells have been found to have levels of IMPD that are >10 times higher than those of normal liver cells (37) . Moreover, studies of normal adult, fetal, and regenerating liver tissue have suggested that there is an inverse relationship between levels of this enzyme and the degree of terminal differentiation of the cells (38) . Therefore, our findings support the concept that alterations in the normal regulation of IMPD may interfere with a cell's capacity to undergo terminal maturation and suggest that this enzyme is an appropriate target for the development of antineoplastic chemotherapy.
